Trials / Completed
CompletedNCT00896233
Magnetic Resonance Elastography for Assessment of Liver Fibrosis (MK-0000-132)(COMPLETED)
Test-Retest Repeatability Study of Magnetic Resonance Elastography (MRE) for Liver Fibrosis Assessment in Healthy Volunteers and Hepatitis C Virus-Infected Patients
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study will assess the repeatability of Magnetic Resonance Elastography (MRE) in both healthy volunteers and Hepatitis C Virus (HCV)-infected patients with fibrosis and lay the groundwork for the validation of MRE as an alternative to liver biopsy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | MRE | Part 1: Participants will have a screening visit, followed \~1 month later by two imaging visits over \~14 days. Each imaging visit will consist of two liver MRE scans. Part 2: Participants will have a screening visit, followed \~1 month later by one imaging visit. The imaging visit will consist of two liver MRE scans. |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2010-01-01
- Completion
- 2010-01-01
- First posted
- 2009-05-11
- Last updated
- 2015-08-25
- Results posted
- 2011-09-22
Source: ClinicalTrials.gov record NCT00896233. Inclusion in this directory is not an endorsement.